Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
58.6M
-
Number of holders
-
144
-
Total 13F shares, excl. options
-
57.3M
-
Shares change
-
-2.25M
-
Total reported value, excl. options
-
$1.88B
-
Value change
-
-$91.3M
-
Put/Call ratio
-
1.57
-
Number of buys
-
64
-
Number of sells
-
-85
-
Price
-
$32.87
Significant Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) as of Q4 2021
195 filings reported holding AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q4 2021.
AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) has 144 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57.3M shares
of 58.6M outstanding shares and own 97.64% of the company stock.
Largest 10 shareholders include FMR LLC (5.43M shares), BlackRock Inc. (5.41M shares), WELLINGTON MANAGEMENT GROUP LLP (5.15M shares), VANGUARD GROUP INC (5.07M shares), Bellevue Group AG (4.35M shares), JPMORGAN CHASE & CO (3.1M shares), STATE STREET CORP (2.99M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.88M shares), Rock Springs Capital Management LP (2.65M shares), and Casdin Capital, LLC (2.09M shares).
This table shows the top 144 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.